acridines has been researched along with Neutropenia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blessing, JA; DeGeest, K; Husseinzadah, N; Lentz, SS; Olt, G; Plaxe, SC; Valea, FA | 1 |
Adjei, AA; Alberts, SR; Ames, MM; Atherton, P; Boemer, SA; Erlichman, C; Goldberg, RM; Hanson, LJ; Kaufmann, SH; Pitot, HC; Reid, JM; Ruben, S; Sloan, JA | 1 |
Ames, MM; Buckner, JC; Galanis, E; Hammack, JE; Kuffel, MJ; Kuross, SA; Maurer, MJ; Pipoly, G; Reid, JM; Scheithauer, BW | 1 |
Bowling, MK; Chen, TL; Donehower, RC; Grochow, LB; Kaufmann, SH; Lubejko, BG; Noe, DA; Rowinsky, EK; Sartorious, SE | 1 |
Adamson, PC; Arndt, C; Balis, FM; Berg, SL; Blaney, SM; Blatt, J; O'Brien, M; Poplack, DG | 1 |
Heilbrun, LK; Kraut, M; LoRusso, P; Philip, PA; Shields, AF; Vaitkevicius, V; Zalupski, MM | 1 |
Budd, GT; Bukowski, RM; Ganapathi, R; McLain, D; Olencki, T; Peereboom, D; Pelley, R; Rybicki, L; Wood, L | 1 |
Hamedani, A; Tosi, MF | 1 |
Amphlett, NW; Hadley, AG; Lucas, GF; Poole, GD | 1 |
7 trial(s) available for acridines and Neutropenia
Article | Year |
---|---|
A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Topics: Acridines; Adult; Aged; Carcinoma, Squamous Cell; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Intercalating Agents; Middle Aged; Neutropenia; Nucleic Acid Synthesis Inhibitors; Pyrazoles; Remission Induction; Salvage Therapy; Treatment Outcome; Uterine Cervical Neoplasms; Vomiting | 2002 |
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
Topics: Acridines; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; DNA Adducts; Drug Interactions; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Platinum; Pyrazoles | 2002 |
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.
Topics: Acridines; Adult; Aged; Anticonvulsants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cytochrome P-450 Enzyme System; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Pyrazoles; Treatment Outcome | 2005 |
Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.
Topics: Acridines; Adult; Aged; Antineoplastic Agents; Central Nervous System; Colorectal Neoplasms; DNA, Neoplasm; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intercalating Agents; Male; Middle Aged; Neutropenia; Ovarian Neoplasms; Pyrazoles; Remission Induction; Uterine Cervical Neoplasms | 1995 |
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.
Topics: Acridines; Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Pyrazoles; Thrombocytopenia | 1998 |
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.
Topics: Acridines; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Pancreatic Neoplasms; Pyrazoles; Thrombocytopenia; Treatment Outcome | 1998 |
A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer.
Topics: Acridines; Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Female; Humans; Intercalating Agents; Male; Middle Aged; Neoplasm Metastasis; Nervous System Diseases; Neutropenia; Pyrazoles; Rectal Neoplasms | 2000 |
2 other study(ies) available for acridines and Neutropenia
Article | Year |
---|---|
A rapid, specific assay for superoxide release from phagocytes in small volumes of whole blood.
Topics: Acridines; Adolescent; Adult; Biological Assay; Child; Child, Preschool; Cytochrome c Group; Granulomatous Disease, Chronic; Humans; Infant; Neutropenia; Phagocytes; Sensitivity and Specificity; Superoxides | 1992 |
The use of interferon-gamma-treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance.
Topics: Acridines; Adult; Autoantibodies; Autoimmune Diseases; Blood Platelets; Erythroblastosis, Fetal; Erythrocytes; Female; Granulocytes; Hemagglutinins; Humans; Hydrogen-Ion Concentration; Immunoglobulin G; Infant, Newborn; Interferon-gamma; Isoantibodies; Luminescent Measurements; Male; Monocytes; Neutropenia; Opsonin Proteins; Phagocytosis; Postpartum Period; Pregnancy; Purpura, Thrombocytopenic, Idiopathic; Receptors, IgG; Recombinant Proteins; Reproducibility of Results; Rho Factor; Sensitivity and Specificity; Thrombocytopenia; Tumor Cells, Cultured | 1992 |